Literature DB >> 22728488

Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy.

Go Kanzaki1, Nobuo Tsuboi, Yoichi Miyazaki, Takashi Yokoo, Yasunori Utsunomiya, Tatsuo Hosoya.   

Abstract

This report presents a human immunodeficiency virus (HIV) patient that developed a slowly progressive renal impairment over years under highly active antiretroviral therapy (HAART). The renal biopsy showed diffuse tubulointerstitial nephritis accompanied by crystal formations that were surrounded by multinuclear giant cells. Furthermore, rod-like crystals were detected in the urinary sediments. Tenofovir and Atazanavir were thought to be the causative drugs for the renal injury. Therefore, the possibility of HARRT-induced nephrotoxicity should be considered in HIV-infected patients, even though the activity of HIV is controlled by such therapies.

Entities:  

Mesh:

Year:  2012        PMID: 22728488     DOI: 10.2169/internalmedicine.51.7093

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

Review 1.  Clinical Pharmacology in HIV Therapy.

Authors:  Mohamed G Atta; Sophie De Seigneux; Gregory M Lucas
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-29       Impact factor: 8.237

Review 2.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

3.  The renal pathological findings in Japanese HIV-infected individuals with CKD: a clinical case series from a single center.

Authors:  Masaki Hara; Kumiko Momoki; Masamitsu Ubukata; Akihito Ohta; Akiko Tonooka; Minoru Ando
Journal:  Clin Exp Nephrol       Date:  2017-06-08       Impact factor: 2.801

Review 4.  Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients.

Authors:  Minoru Ando; Naoki Yanagisawa
Journal:  World J Nephrol       Date:  2015-07-06

5.  Atazanavir nephrotoxicity.

Authors:  Masaki Hara; Akihiko Suganuma; Naoki Yanagisawa; Akifumi Imamura; Tsunekazu Hishima; Minoru Ando
Journal:  Clin Kidney J       Date:  2015-03-20

Review 6.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21

7.  Atazanavir Crystal-Induced Chronic Granulomatous Interstitial Nephritis.

Authors:  Vipin Varghese; Rafael Rodriguez; Sally Self; Juan Carlos Q Velez
Journal:  Kidney Int Rep       Date:  2020-04-17

8.  Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function.

Authors:  Maria Concetta Postorino; Eugenia Quiros-Roldan; Franco Maggiolo; Simona Di Giambenedetto; Nicoletta Ladisa; Giuseppe Lapadula; Silvia Lorenzotti; Laura Sighinolfi; Filippo Castelnuovo; Massimo Di Pietro; Daria Gotti; Nicola Mazzini; Carlo Torti
Journal:  Open AIDS J       Date:  2016-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.